FDA to Cut Back Hiring of Non-US Citizens

The move appears to be out of step with other HHS agencies.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FDA building with signFDAHiring managers at the US Food and Drug Administration (FDA) will soon be unable to extend offers to non-citizens who have lived in the United States for fewer than three of the past five years, reports STAT. The policy, attributed to changes in the background check procedures needed to procure a government employee ID card, does not appear to be in line with policies at other federal science agencies, STAT finds.

A government policy on the ID cards, implemented in 2008, stipulates that applicants must have lived in the country for at least three of the preceding five years in order to complete the background check—but it also suggests that those who do not meet the requirement can be hired and use a different type of card until eligible.

An FDA document obtained by STAT states that the agency’s hiring change is due to a January 2017 update to that policy. Yet, “an HHS spokesman said the internal document did not include new policies on a residency requirement,” the outlet reports.

The order, expected to take effect October 1, will not apply to current employees. Nevertheless, two FDA staffers tell STAT they were “dismayed” and “stunned” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio